Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Epigenetics in Drug Discovery

Epigenetics in Drug Discovery

Date: Tuesday, 26 January 2016 - Wednesday, 27 January 2016
Location: Cambridge, UK


Plenary Speakers

Scott Ribich

Scott Ribich
Associate Director, Epizyme

Keynote Speakers

Rabinder Prinjha

Rabinder Prinjha
Vice President, GlaxoSmithKline

Overview

SELECTBIO is pleased to announce Epigenetics in Drug Discovery 2016, which will be held on 26 - 27 January 2016 in Cambridge, UK. The event is part of our Cambridge Workshop Series. 

Attracting researchers, academics and industry professionals working in epigenetic research, this event will explore the potential of epigenetics to contribute towards novel and existing therapeutics, across significant areas of unmet need. Emerging technologies, epigenetic changes and cellular reprogramming will also be discussed, with special attention paid to drug discovery and development. 

Viewed as a new frontier in drug discovery, rapid progress has been made in our understanding of epigenetic mechanisms of both new and existing drugs. With the processes that control epigenomic function providing new opportunities, epigenetics targets are enabling the discovery of novel drugs. 

If you work in drug discovery research you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of epigenetics research, whilst networking with the technology providers who are enabling them to do so.

Agenda Topics

  • DNA Methylation
  • Histone Modifications
  • Next Generation Epitherapeutics
  • Regulation of Genomic Functions

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Paul Bamborough, Computational Chemistry Section Head, GlaxoSmithKline
Amy Beynon, Product Development Manager, Chromatrap
Stuart Conway, Professor, University Of Oxford
Emilia Danilowicz-Luebert, Field Product Specialist, Diagenode
Menno de Winther, Professor, University Of Amsterdam
Jude Fitzgibbon, Professor, Queen Mary University Of London
Christian Fritz, Vice President, Syros
Bernard Haendler, , Bayer Healthcare
Tim Humphrey, Associate Professor, University Of Oxford
Matthew Jarpe, Associate Vice President Of Biology, Acetylon Pharmaceuticals
Manfred Jung, Chemical Epigenetics Group Leader, Universit├Ąt Freiburg
Tamara Maes, Chief Scientific Officer, Oryzon
Craig Malcolm, Strategic Collaborations Manager, Promega UK Ltd
Ralph Mazitschek, Assistant Professor, Broad Institute Of MIT And Harvard
Susanne Muller Knapp, Group Head Structural Genomics Consortium (SGC), University Of Oxford
Jun Qi, Lead Scientist, Dana Farber Cancer Institute
Moshe Szyf, Professor, McGill University
Takashi Umehara, Unit Leader, RIKEN Center for Life Science Technologies (CLST)


Exhibition Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2016-01-26 00:00:002016-01-27 00:00:00Europe/LondonEpigenetics in Drug DiscoveryEpigenetics in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com